DSpace Repository

Browsing by Author "Edwin, Were"

Browsing by Author "Edwin, Were"

Sort by: Order: Results:

  • Daily Acyclovir Delays HIV-1 Disease Progression Among HIV-1/ HSV-2 Dually-Infected Persons: A Randomized Trial 
    Jairam, R. Lingappa; Jared, M. Baeten; Anna, Wald; James, P. Hughes; Katherine, K. Thomas; Andrew, Mujugira; Nelly, Mugo; Elizabeth, A. Bukusi; Craig R., Cohen; Elly, Katabira; Allan, Ronald; James, Kiarie; Carey, Farquhar; Grace, John Stewart; Joseph, Makhema; Myron, Essex; Edwin, Were; Kenneth, H. Fife; Guy de, Bruyn; Glenda, E. Gray; James, McIntyre; Rachel, Manongi; Saidi, Kapiga; David, Coetzee; Susan, Allen; Mubiana, Inambao; Kayitesi, Kayitenkore; Etienne, Karita; William, Kanweka; Sinead, Delany; Helen, Rees; Bellington, Vwalika; Amalia, Magaret; Richard S., Wang; Lara, Kidoguchi; Linda, Barnes; Renee, Ridzon; Lawrence, Corey; Connie, Celum (NIH Lancet public access, 2010-05-05)
    Background—Well-tolerated medications that slow HIV-1 disease progression and delay initiation of antiretroviral therapy (ART) are needed. Most HIV-1-infected persons are dually-infected with herpes simplex virus type 2 ...
  • Pre-exposure prophylaxis for HIV-1 prevention does not diminish the pregnancy prevention effectiveness of hormonal contraception 
    Pamela m., Murnane; Renee, Heffron; Allan, Ronald; Elizabeth A, . Bukusi; Deborah, Donell; Nelly R, . Mugo; Edwin, Were; Andrew, Mujugira; James, Kiarie; Connie, Celum; Jared M., Baeten (NIH Public Access, 2014-07-07)
    Background—For women at risk of HIV-1, effective contraception and effective HIV-1 prevention are global priorities. Methodology—In a clinical trial of pre-exposure prophylaxis (PrEP) for HIV-1 prevention in HIV-1 ...
  • Pregnancy incidence and outcomes among women receiving pre-exposure prophylaxis for HIV prevention a randomized clinical trial 
    Nelly, R. Mugo; Ting, Hong; Connie, Celum; Deborah, Donnell; Elizabeth, A. Bukusi; Grace, John Stewart; Edwin, Were; Renee, Heffron; Lynn, T. Matthews; Susan, Morrison; Kenneth, Ngure; Jared, M. Baeten; Jonathan, wangisi (american medical association, 2014-07-30)
    IMPORTANCE Antiretroviral preexposure prophylaxis (PrEP), using tenofovir disoproxil fumarate (TDF) and combination emtricitabine/tenofovir disoproxil fumarate (FTC+TDF), is efficacious for prevention of human immunodeficiency ...
  • PrEP is efficacious for HIV-1 prevention among women using DMPA for contraception 
    Heffron, Renee; Nelly, Mugo; Edwin, Were; Kiarie, James; Bukusi, Elizabeth A.; Mujugira, Andrew; Frenkel, Lisa; Donnell, Deborah; Ronald, Allan; Celum, Connie; Baeten, Jared M. (NIH Public Access, 2014)
    Objective: To evaluate preexposure prophylaxis (PrEP) efficacy for HIV-1 prevention among women using depot medroxyprogesterone acetate (DMPA) for contraception and men whose HIV-1-infected partners use DMPA. Design: ...
  • A prospective study of frequency and correlates of intimate partner violence among African heterosexual HIV serodiscordant couples 
    Edwin, Were; Kathryn, Curran; Sinead, Delany-Moretlwe; Edith, Nakku-Joloba; Nelly R, .Mugo; James, Kiarie; Elizabeth A, . Bukusi; Connie, Celum; Jared M, . Baeten (NIH Public Access, 2011-10-10)
    Background—Intimate partner violence (IPV) is common worldwide and is an important consideration in couples HIV voluntary counseling and testing (CVCT), especially for HIV serodiscordant couples (i.e., in which only one ...